Humaid Al-Shamsi: Welcoming Marwan Ghosn to Burjeel Cancer Institute
Humaid Al-Shamsi shared on LinkedIn:
“We welcome Marwan Ghosn to Burjeel Cancer Institute.
Professor Marwan Ghosn obtained his medical degree and postgraduate expertise in Hematology and Oncology from Saint-Joseph University, Faculty of Medicine, in Beirut, Lebanon. Additionally, he trained at the University of Paris XI – Kremlin-Bicêtre and the Institute Gustave Roussy Cancer Center in Villejuif, France.
Currently, he is the Director of the Hematology-Oncology Postgraduate Program and the Chairman of the Hematology-Oncology Department at Saint-Joseph University, Faculty of Medicine in Beirut.
Professor Ghosn also holds a Master’s in Hospital and Health Management from The Higher School of Business, ESA, in Beirut, and a Master’s in the Quality Management of Units for Care Production (MUPS) from the University of Paris VII, Denis Diderot, France.
He serves as the Director of the Cancer Center and the Head of the Hematology and Oncology Division at Clemenceau Medical Center, affiliated with Johns Hopkins International in Beirut.
For over 12 years, Professor Ghosn has been the Chairman of the Hematology-Oncology Department at Hotel-Dieu de France University Hospital in Beirut, where he continues his clinical, medical, and research activities.
He has also held the position of President of the Lebanese Society of Medical Oncology (LSMO) and was a board member of the Lebanese Cancer Society (LCS) for many years.
He is an active member of several national and international scientific organizations and societies, including the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), the European Society for Medical Oncology (ESMO), the American Society of Hematology (ASH), the European Hematology Association (EHA), the International Society of Geriatric Oncology (SIOG), and the Arab Medical Association Against Cancer (AMAAC).
Professor Ghosn is the author and co-author of more than 200 peer-reviewed articles. He has presented numerous communications, posters, and abstracts at regional and international meetings and has contributed several chapters to books in the fields of Medical Oncology and Healthcare Management.
He is the Editor-in-Chief of the ‘Pan Arab Journal of Oncology’ (PAJO), published by the Arab Medical Association Against Cancer (AMAAC), and has previously served as Editor-in-Chief of the ‘Cancer Letter,’ published by the Lebanese Cancer Society.
Professor Ghosn’s research interests include leadership in conducting research and clinical trials in solid tumors. He has expertise in breast cancer, urologic cancers, gastrointestinal tumors, geriatric oncology, and patient safety and quality in healthcare.”
Source: Humaid Al-Shamsi/LinkedIn
Prof. Humaid Al Shamsi is the Founder and Director of Medical Oncology at Burjeel Medical City. He serves as President of the Emirates Oncology Society and Adjunct Clinical Professor of Oncology at the University of Sharjah.
Prof. Humaid holds board certifications from the USA, Canada, and the UK in medical oncology and internal medicine. Recognized as the sole certified Gastrointestinal Oncologist in the UAE, his practice focuses on various solid tumors, including breast, colon, gastric, and lung cancers.
Additionally, he’s the first UAE national trained in palliative care, and he actively advises governmental committees to improve cancer care standards in the UAE and the region.